Status:
COMPLETED
Metabolomic Profile in Breastfed Late Preterm Infants
Lead Sponsor:
Ospedale Buon Consiglio Fatebenefratelli
Collaborating Sponsors:
University of Salerno
Conditions:
Formula Milk
Breast Milk Collection
Eligibility:
All Genders
34-37 years
Brief Summary
Exclusive breast milk is recommended from birth to 6 months of life to promote the development of a balanced intestinal microbiota. Human milk provides several bioactive components, from natural probi...
Detailed Description
A balanced nutrition starting from early childhood significantly influences growth and psychomotor development. Exclusive breast milk is the recommended nutritional choice from birth to 6 months of li...
Eligibility Criteria
Inclusion
- Weight appropriate to gestational age (percentiles \>10th and \<90th)
- Written informed consent
Exclusion
- Cardiological diseases
- Liver disease
- Gastrointestinal diseases with malabsorption
- Endocrinological diseases
- Perinatal infections
- Metabolic and genetic diseases
- Born to mothers with endocrinological and metabolic diseases
- Withdrawal of informed consent
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06052592
Start Date
March 1 2022
End Date
November 1 2023
Last Update
September 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pharmacy, University of Salerno
Salerno, Naples, Italy, 84084
2
Department of Woman and Child, Buon Consiglio Fatebenefratelli Hospital
Napoli, Napoli, Italy, 80123